
Sensus Healthcare, Inc.
SRTSNASDAQHealthcareMedical - Devices
Previous close
$3.34
+$0.11 · +3.41%
SRTS company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
57
Fair Value
Momentum
26
Weakening
Sentiment
72
Bullish
Risk resilience
31
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteSensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy. This device presents a non-surgical alternative for patients dealing with non-melanoma skin cancers, including basal cell and squamous cell carcinomas, alongside other dermatological issues like keloids. Another key offering is the SRT-100 Vision, which incorporates a specialized SRT treatment planning application. This application seamlessly integrates an embedded high-frequency ultrasound imaging module, tools for volumetric tumor analysis, beam margin delineation, and dosimetry parameter configuration. In addition, Sensus Healthcare provides the SRT-100 Plus, the Sentinel service program to ensure system protection for its clients, and options for in-office laser rentals. They also supply various consumable items, such as replacement lead shielding, disposable radiation safety gear like aprons and eye shields, ultrasound probe film, and single-use applicator tips designed to treat lesions of different sizes and on various body areas. Founded in 2010, Sensus Healthcare, Inc. maintains its corporate headquarters in Boca Raton, Florida.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Joseph C. Sardano
- Listed since
- Jul 26, 2016
- Employees
- 60
Market position
Day range
Current $3.34
52-week range
Current $3.34
- Open
- $3.29
- Previous close
- $3.23
- Volume
- 24.63K
- 0.51× average
- Average volume
- 48.72K
- Average daily volume
- Market cap
- 54.98M USD
- Beta
- 1.12
- Market reference 1
- 50-day average
- $2.9775
- +12.17% above average
- 200-day average
- $3.7916
- -11.91% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 43.58M USD
- P/E (TTM)
- -3.56×
- P/B (TTM)
- 1.49×
- P/S (TTM)
- 3.14×
- EV / EBITDA
- -4.72×
- Earnings yield
- -11.88%
- Free cash flow yield
- 0.51%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 36.39%
- Operating margin
- -75.72%
- Net margin
- -88.45%
- Return on equity
- -16.05%
- Return on assets
- -14.55%
- Return on invested capital
- -17.02%
Financial health
- Debt / equity
- 0.01×
- Current ratio
- 9.72×
- Altman Z-score
- 7.92
- Piotroski F-score
- 2 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 27.48M USD | 41.81M USD | 24.41M USD | 44.53M USD | 27.04M USD |
| Cost of goods sold | 15.62M USD | 17.38M USD | 10.35M USD | 14.9M USD | 10.05M USD |
| Gross profit | 11.87M USD | 24.43M USD | 14.06M USD | 29.63M USD | 16.99M USD |
| Research and development | 7.78M USD | 4.22M USD | 3.68M USD | 3.46M USD | 3.44M USD |
| Selling, general, and administrative | 14.4M USD | 12.13M USD | 10.76M USD | 11.34M USD | 9.43M USD |
| Operating expenses | 22.17M USD | 16.34M USD | 14.44M USD | 14.8M USD | 12.87M USD |
| Interest income | 683K USD | 932K USD | 992K USD | 382K USD | 2K USD |
| Interest expense | — | — | — | 2K USD | 1K USD |
| Depreciation and amortization | 386K USD | 432K USD | 461K USD | 509K USD | 613K USD |
| Operating income | −10.31M USD | 8.09M USD | −382K USD | 14.83M USD | 4.12M USD |
| Net income | −7.72M USD | 6.65M USD | 485K USD | 24.24M USD | 4.12M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 45%
- 5 beats, 6 misses, 0 met estimates
- Average EPS surprise
- -12.45%
- 11 comparable reports
- Latest EPS result
- -0.53
- Estimate -0.13 · Miss by 324.00%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$4.75
42.22% upsideRating distribution
9 ratingsRecent analyst actions
SRTS news
SRTS peers
ETFs holding SRTS
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI1.44M0.00%2.3T USD0.03%$378.24+0.44%
Vanguard Extended Market ETFVXF450.09K0.00%93.7B USD0.05%$245.53+0.82%
iShares Micro-Cap ETFIWC151.72K0.01%1.53B USD0.60%$198.39+1.10%
Dimensional - US Small Cap ETFDFAS94.1K0.00%15.92B USD0.26%$83.02+0.73%
Dimensional - US Small Cap Value ETFDFSV92.27K0.00%8.42B USD0.30%$40.29+0.72%
Dimensional - US Core Equity 2 ETFDFAC69.7K0.00%49.31B USD0.17%$45.61+0.46%
Avantis U.S. Small Cap Equity ETFAVSC64.7K—3.16B USD0.25%$73.84+0.70%
U.S. Micro Cap Portfolio ETFDFMC43.61K0.00%8.06B USD0.43%$60.95+0.73%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 1.44M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard Extended Market ETFVXF- Market value
- 450.09K
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Micro-Cap ETFIWC- Market value
- 151.72K
- Weight
- 0.01%
- AUM
- 1.53B USD
- Expense ratio
- 0.60%
- Price / 1D
- $198.39+1.10%
Dimensional - US Small Cap ETFDFAS- Market value
- 94.1K
- Weight
- 0.00%
- AUM
- 15.92B USD
- Expense ratio
- 0.26%
- Price / 1D
- $83.02+0.73%
Dimensional - US Small Cap Value ETFDFSV- Market value
- 92.27K
- Weight
- 0.00%
- AUM
- 8.42B USD
- Expense ratio
- 0.30%
- Price / 1D
- $40.29+0.72%
Dimensional - US Core Equity 2 ETFDFAC- Market value
- 69.7K
- Weight
- 0.00%
- AUM
- 49.31B USD
- Expense ratio
- 0.17%
- Price / 1D
- $45.61+0.46%
Avantis U.S. Small Cap Equity ETFAVSC- Market value
- 64.7K
- Weight
- —
- AUM
- 3.16B USD
- Expense ratio
- 0.25%
- Price / 1D
- $73.84+0.70%
U.S. Micro Cap Portfolio ETFDFMC- Market value
- 43.61K
- Weight
- 0.00%
- AUM
- 8.06B USD
- Expense ratio
- 0.43%
- Price / 1D
- $60.95+0.73%
Continue in GoAI
Research SRTSresearch.disclaimer









